JP Morgan Private Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$388K	Sell	2,158 -440	-17%	-$87.1K	﹤0.01%	1352
2023 Q2	$463K	Sell	2,598 -2,831	-52%	-$652K	﹤0.01%	1071
2023 Q1	$1.17M	Buy	5,429 +95	+2%	+$22.8K	﹤0.01%	1102
2022 Q4	$1.17M	Sell	5,334 -1,152	-18%	-$211K	﹤0.01%	1076
2022 Q3	$874K	Sell	6,486 -328	-5%	-$56.3K	﹤0.01%	1204
2022 Q2	$1.1M	Sell	6,814 -68	-1%	-$10.6K	﹤0.01%	1094
2022 Q1	$1.3M	Buy	6,882 +2,098	+44%	+$446K	﹤0.01%	1088
2021 Q4	$1.3M	Buy	4,784 +130	+3%	+$43.9K	﹤0.01%	1110
2021 Q3	$1.69M	Buy	4,654 +281	+6%	+$91.9K	﹤0.01%	962
2021 Q2	$1.5M	Buy	4,373 +720	+20%	+$238K	﹤0.01%	1009
2021 Q1	$1.27M	Sell	3,653 -4	-0.1%	-$1.32K	﹤0.01%	937
2020 Q4	$945K	Buy	3,657 +792	+28%	+$218K	﹤0.01%	1023
2020 Q3	$821K	Buy	+2,865	New	+$673K	﹤0.01%	964

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ONC Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its BeOne Medicines Ltd (ONC) stake by 17% in Q3 2023, selling an estimated $87.1K and leaving 2,158 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

JP Morgan Private Wealth Advisors first reported a position in ONC in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.69M in Q3 2021. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

JP Morgan Private Wealth Advisors held 2,158 shares of BeOne Medicines Ltd worth $388K as of Q3 2023.
JP Morgan Private Wealth Advisors sold 440 BeOne Medicines Ltd shares in Q3 2023, an estimated $87.1K.
BeOne Medicines Ltd made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1352 holding.
JP Morgan Private Wealth Advisors first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 13 quarters since.
JP Morgan Private Wealth Advisors's BeOne Medicines Ltd position peaked at $1.69M in Q3 2021.
201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.